AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Suitglip-M 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Suitglip-M 50/500 Tablet

Glimepiride/Metformin 50/500 mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate serious diabetic complications like nephropathy and retinopathy, potentially lowering the risk of cardiovascular events. This medication may be prescribed as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and concomitant medications. Consuming the tablets with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinue only under your physician's guidance. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management; lifestyle choices significantly impact disease control. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; learn to recognize and manage this condition. This medication isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, or heart disease, pancreatic disorders, or excessive alcohol consumption before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Primary Ingredients of Suitglip-M 50/500 Tablet

No text was provided to rewrite.

Uses of Suitglip-M 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Suitglip-M 50/500 Tablet:

Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Suitglip-M 50/500 Tablet with food.

Common Side effects of Suitglip-M 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Suitglip-M 50/500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Suitglip-M 50/500 with a meal.

How Suitglip-M 50/500 Tablet works:

Suitglip-M 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Suitglip-M 50/500 Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Suitglip-M 50/500 tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Suitglip-M 50/500 Tablets while breastfeeding is likely inadvisable. Scant evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Suitglip-M 50/500 Tablets cautiously, potentially requiring dosage modification. Medical advice is essential. The medication is contraindicated in patients exhibiting severe kidney dysfunction. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Suitglip-M 50/500 Tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Suitglip-M 50/500 Tablet :

Should you forget a Suitglip-M 50/500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Suitglip-M 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Suitglip-M 50/500 Tablet

Suitglip-M 50/500 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Suitglip-M 50/500 Tablet use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Suitglip-M 50/500 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Suitglip-M 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Suitglip-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Suitglip-M 50/500) can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Suitglip-M 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Suitglip-M 50/500 Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Suitglip-M 50/500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Suitglip-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Suitglip-M 50/500) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Suitglip-M 50/500 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Suitglip-M 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Suitglip-M 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Suitglip-M 50/500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Suitglip-M 50/500 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Suitglip-M 50/500) can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Suitglip-M 50/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive yearly supplemental vitamin B12 is suggested by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Suitglip-M 50/500 Tablet
85
MRP 99
14% off